Greenberg, Milton L
- Vivreon Biosciences, LLC (no department on record)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #3,964
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2016 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2027.
NIH Funding · FY2023
Linked Award Amount
$1.9M
Full award amounts, FY2023
Award Records
4
Records listing this PI
Award-Linked Rank
#3,964
By linked amount among FY2023 PIs
Earliest Year Loaded
2016
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Greenberg, Milton L as a PI. Multi-PI records show the full award amount for context.
- 5R44AG061995-03R44Contact PIPreclinical Characterization of CRAC Channel Inhibitors for the Treatment of Alzheimer's Disease$1.2Maward amount
- 1R43HL167426-01R43Contact PIDevelopment of a Novel Calcium Channel Therapeutic for the Treatment of Asthma$352Kaward amount
- 1R44DA058467-01R44Contact PIDevelopment of a Novel Calcium Channel Therapeutic for Opioid Use Disorder$320Kaward amount
- 3R44AG061995-03S1R44Contact PIPreclinical Characterization of CRAC Channel Inhibitors for the Treatment of Alzheimer's Disease$50Kaward amount
Award organization
Organizations that administered FY2023 awards listing Greenberg, Milton L as a PI.
FY2023 award administered by Vivreon Biosciences, LLC (CA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2016First NIH AwardVivreon Biosciences, LLC
- 2017$500K Cumulative Funding
- 2017$1M Cumulative Funding
- 2017Entered Top 50% NationallyRanked #7290
- 2018$2M Cumulative Funding
- 2019Entered Top 25% NationallyRanked #2149
- 2020$5M Cumulative Funding
- 2020Entered Top 10% NationallyRanked #1988
- 2023$10M Cumulative Funding